Unclassified
PathAI
PathAI develops AI models that analyze pathology slides to generate biomarkers for biopharma R&D.
Compare PathAIDeployment
Not publicly documented
Headquarters
Boston, MA, USA
Website
Open public pageReviewed evidence
Open public pageCompany status and public evidence links last reviewed Aug 27, 2026. Category, headquarters, deployment, and integration fields are derived from vendor-described public materials. Certification entries are tracked disclosures, not independent verification.
Canonical evidence
Monitored public sources
No canonical monitoring source has been approved for this legacy record yet.
Only reviewed and approved change events are public. Current approved events: 0. Reviewed claims: 0.
Latest intelligence
Approved change history
Regulatory exposure indicates frameworks relevant to procurement review. It does not, by itself, represent a legal conclusion or verified compliance status.
No recent public changes are recorded.
Observation History
No public changes recorded yet
GovernAtlas has not added a sourced observation for this vendor in the current seed dataset.
Observation cadence
Recorded change frequency
Monthly counts reflect public changes in the current GovernAtlas seed dataset, not the vendor's complete internal compliance activity.
No observation cadence is available yet.
Related intelligence
More in Unclassified
Alloy
Alloy provides an identity decisioning platform that consolidates data from multiple KYC, KYB, and fraud vendors to automate customer onboarding.
Anduril Lattice
Anduril develops AI-enabled defense systems including the Lattice software platform for military operations.
Atomwise
Atomwise uses deep learning for structure-based drug design, screening billions of compounds.